Logo image of SILO

SILO PHARMA INC (SILO) Stock News

NASDAQ:SILO - Nasdaq - US82711P2011 - Common Stock - Currency: USD

0.6421  +0.07 (+12.45%)

SILO Latest News, Press Relases and Analysis

News Image
6 hours ago - Chartmill

These stocks are moving in today's pre-market session

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Mentions: WGO BW RETO CBUS ...

News Image
22 hours ago - Chartmill

Stay updated with the stocks that are on the move in today's after-hours session.

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Mentions: BOLT PVH MFI PL ...

News Image
6 hours ago - Silo Pharma, Inc.

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Strategic decision positions Company to diversify treasury holdings with a long-term digital store of value

News Image
6 hours ago - Silo Pharma, Inc.

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Strategic decision positions Company to diversify treasury holdings with a long-term digital store of value ...

News Image
15 days ago - Silo Pharma, Inc.

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Study is expected to deliver final device data and documentation needed for planned FDA IND submission

News Image
15 days ago - Silo Pharma, Inc.

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Study is expected to deliver final device data and documentation needed for planned FDA IND submission...

News Image
20 days ago - Silo Pharma, Inc.

Silo Pharma Announces Closing of $2 Million Public Offering

SARASOTA, FL, May 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...

News Image
21 days ago - Silo Pharma, Inc.

Silo Pharma Announces Pricing of $2 Million Public Offering

SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...

News Image
22 days ago - Stocktwits

Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment

The company announced FDA-requested toxicology studies for its PTSD treatment SPC-15, fueling optimism for a 2025 IND submission and Phase 1 trial.

News Image
22 days ago - Silo Pharma, Inc.

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...

News Image
22 days ago - Silo Pharma, Inc.

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Clear Regulatory Path to Clinical Trials for Intranasal PTSD Therapy Targeting Multi-Billion-Dollar Market

News Image
22 days ago - Silo Pharma, Inc.

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Clear Regulatory Path to Clinical Trials for Intranasal PTSD Therapy Targeting Multi-Billion-Dollar Market...

News Image
a month ago - Silo Pharma, Inc.

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....

News Image
a month ago - Silo Pharma, Inc.

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...

News Image
2 months ago - Silo Pharma, Inc.

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....

News Image
3 months ago - Silo Pharma, Inc.

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

SARASOTA, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical...

News Image
4 months ago - Silo Pharma, Inc.

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

SPC-15 combination treatment shows enhanced efficacy in combating stress-induced psychiatric disorders SARASOTA, FL, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ...

News Image
4 months ago - Silo Pharma, Inc.

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11, 2025 (GLOBE NEWSWIRE) --...